State of Impatience

Volume 1: Impatience is a Virtue

Part 1: Reclaiming Impatience

‘You may delay, but time will not.’

— Benjamin Franklin, Poor Richard's Almanack

Time doesn't wait for permission, and Franklin's almanac returns to that point elsewhere too: lost time, unlike lost money, is never recovered. For a family living with a rare genetic condition, delay isn't a pause in the story. It's the next chapter, whether anyone intended it or not.

Impatience, when disciplined and grounded, is not recklessness. It is the only morally serious response to someone who is suffering and in desperate need of answers — especially people living with rare genetic conditions.

These people do not experience the drug development timeline as a system constraint. They experience it as the texture of their daily life — as the number of stairs they can still climb, as the words their child has not yet lost. When we talk about moving faster, we are talking about the distance between where those people are and where the science already is. That distance is not technical. It is moral.

Mary has spent years unable to sleep, always waiting for the next hospital trip — one of four generations in her family living with ADH1, most of them undiagnosed. Mason is 18 and gets labs drawn before school and takes Tums at basketball practice to manage his calcium; to anyone watching, he looks fine. Brady could tolerate 32 seconds of sunlight before deep burning pain set in, and it took three severe episodes before a specialist who had seen exactly one prior case recognized EPP. For each of them, the system’s timeline is not an abstraction. It is the shape of their week.

Sophie was told by an older girl with LGMD: “Wait until you turn 10 — it’s all over from there.” She stopped gymnastics at 11 and didn’t want a birthday, her future arriving in every older patient she met. Clara, who is nine and has achondroplasia, introduces herself to other children on the playground by leading with her condition — to skip past other people’s discomfort and get straight to living. Impatience is what Sophie’s disease demands. It is what Clara innately practices.

The refusal to accept that a patient community deserves any less speed than the science can deliver is the version of impatience worth building toward. It asks: where is the delay that doesn’t have to exist? Who is paying for it? What will it take to close that distance?

Part 2: Impatience as a Design Constraint

‘You never change anything by fighting it; you change things by making them obsolete through superior technology.’

— Buckminster Fuller, Think Out of the Box by Mike Vance and Diane Deacon

Fuller was talking about systems design. So is this section. Saying “patients first” is fighting the existing reality with words. Building organizations that actually decide faster, kill programs sooner, and surface uncertainty early — that’s building the new model.

“Patients first” is easy to say — and many in the industry do say it quite a bit. But you cannot just claim it. You have to hire for it, and you have to build your systems to value it, which is the harder part. And then you will be asked to prove it.

This doesn’t mean being impulsive. It means designing organizations that make decisions earlier rather than later — that surface uncertainty instead of managing it into silence, and that stop programs when evidence demands it, even when it’s hard. Because an honest “no” today is a faster “yes” for a different patient tomorrow.

Daniel was diagnosed at six with TSC and spent his childhood in MRI machines. As an adult, his worry is that people with his disease feel so forgotten they lose hope entirely. Parker’s TSC was found at 35 weeks in utero; he was in the cardiac ICU within days of birth and checked for tumors across multiple organs. Current treatments suppress growth but hit every cell in the body, and his parents’ question is whether medicine could ever be precise enough to do better. Both of them are asking for the same thing: not reassurance, but clarity—and most importantly, knowing that they can expect a future with answers--even if it’s not the one they want to hear.

Part 3: Impatience Should Be Measurable

‘If you challenge the conventional wisdom, you will find ways to do things much better than they are currently done.’

— Michael Lewis, Moneyball: The Art of Winning an Unfair Game

Florence Nightingale didn’t discover that soldiers were dying from preventable infections — everyone in the hospital already knew it. She made it undeniable by turning mortality data into a diagram that Parliament couldn’t ignore. The measurement didn’t create the problem. It created the obligation to act.

Elliott’s parents were told he likely wouldn’t survive to school age; his disorder, Molybdenum Cofactor Deficiency Type A, causes devastating neurological damage within hours of birth. A phone call sent them racing to Manchester in the middle of the night to access experimental treatment sourced from the University of Cologne. That’s what time means in this field — not quarterly earnings or approval cycles, but hours, and often the difference between life and death.

All of this matters because Mary is still losing sleep. Mason still has early labs. Elliott’s parents are still watching the clock. Sophie is still dreading birthdays. Daniel is still worried his community will lose hope. Parker’s parents are still waiting for precision. Brady is still tracking the minutes he can stand in sunlight. Clara is still introducing herself so others don’t have to ask.

As long as that is still the case — don’t we owe it to them to forge ahead as they do in their daily lives? To not take no for an answer? To make hard decisions? To make our work a mirror of their relentless energy to find answers?

—

There are over 10,000 rare genetic diseases and only 500 have approved therapies. That’s why we’re impatient for patients.